Study directory

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Back to overview
270studies shown
Showing 1-12 of 270
Drug study icon
RecruitingNCT06696755

Adverse Events and Change for Bipolarity

This study is recruiting in the United States. It is testing adverse Events and Change for Bipolarity.

Multiple locations, including Huntsville
Why is this study shown?

This study is directly about Bipolarity.

BipolarityDrugA study involving a medication or substance.From 18 Years to 65 Years
Countries
United States
Sponsor
AbbVie
Condition
Bipolarity
Drug study icon
RecruitingNCT06929273

KarXT for manic episodes in bipolarity type I

This study is recruiting in the United States, in Australia, in France, .... It is testing KarXT for manic episodes in bipolarity type I.

Multiple locations, including Glendale
Why is this study shown?

This study is directly about Bipolarity.

BipolarityDrugFrom 18 Years to 65 Years
Countries
United States, Australia, France, ...
Sponsor
Bristol-Myers Squibb
Condition
Bipolarity
Drug study icon
RecruitingNCT07140913

KarXT for manic episodes in bipolarity type I

This study is recruiting in the United States, in France, in Argentina, .... It is testing KarXT for manic episodes in bipolarity type I, including participants taking lithium, valproate, or lamotrigine.

Multiple locations, including Bentonville
Why is this study shown?

This study is directly about Bipolarity.

BipolarityDrugFrom 18 Years to 65 Years
Countries
United States, France, Argentina, ...
Sponsor
Bristol-Myers Squibb
Condition
Bipolarity
Drug study icon
RecruitingNCT07288320

An Assessment of Efficacy, Safety, and Pharmacokinetics of NBI-1117568 in Adults With Bipolarity type I With Current Mania

This study is looking at care and outcomes for people with Bipolarity I or Mania. Some participants may receive placebo instead of the study treatment, and direct benefit is not guaranteed.

Multiple locations, including Garden Grove
Why is this study shown?

This study is directly about Bipolarity.

BipolarityDrugFrom 18 Years to 65 Years
Countries
United States
Sponsor
Neurocrine Biosciences
Condition
Bipolarity
Drug study icon
RecruitingNCT06951698

KarXT for manic episodes in bipolarity type I

This study is recruiting in the United States, in Australia, in New Zealand, .... It is testing KarXT for manic episodes in bipolarity type I.

Multiple locations, including Bentonville
Why is this study shown?

This study is directly about Bipolarity.

BipolarityDrugFrom 18 Years to 65 Years
Countries
United States, Australia, New Zealand, ...
Sponsor
Bristol-Myers Squibb
Condition
Bipolarity
Drug study icon
RecruitingNCT06951711

KarXT for manic episodes in bipolarity type I

This study is recruiting in the United States, in Croatia, in India, .... It is testing KarXT for manic episodes in bipolarity type I.

Multiple locations, including Little Rock
Why is this study shown?

This study is directly about Bipolarity.

BipolarityDrugFrom 18 Years to 65 Years
Countries
United States, Croatia, India, ...
Sponsor
Bristol-Myers Squibb
Condition
Bipolarity
Drug study icon
RecruitingNCT07286175

Brenipatide in adults with Bipolarity (RENEW-Bipolar-1)

This study is recruiting in the United States, in Argentina, in Brazil, .... It is testing brenipatide for Bipolarity.

Multiple locations, including Orange
Why is this study shown?

This study is directly about Bipolarity.

BipolarityDrugFrom 18 Years to 75 Years
Countries
United States, Argentina, Brazil, ...
Sponsor
Eli Lilly and Company
Condition
Bipolarity
Drug study icon
RecruitingNCT07213466

Individualized Pharmacological Approach to Obesity in people with Bipolarity

This study is looking at whether a digital support tool can help people with bipolarity. Participants receive a study treatment and complete follow-up visits and assessments.

In Rochester
Why is this study shown?

This study is directly about Bipolarity.

BipolarityDrugFrom 18 Years to 65 Years
Countries
United States
Sponsor
Mayo Clinic
Condition
Bipolarity
Behavioral study icon
RecruitingNCT06920940

Child Bipolar Network Ketogenic Diet Approach to Bipolarity in Adolescents

This study is looking at whether psychoeducation can help people with bipolarity. Participants receive a study treatment and complete follow-up visits and assessments.

Multiple locations, including Los Angeles
Why is this study shown?

This study is directly about Bipolarity.

BipolarityBehavioralFrom 12 Years to 21 Years
Countries
United States
Sponsor
University of California, Los Angeles
Condition
Bipolarity
Other study type icon
RecruitingISRCTN75279027

Examination of a web-based Integrated Bipolar Parenting Intervention (IBPI) for bipolar parents of young children (aged 3-10)

This study is looking at whether a digital support tool can help people with bipolarity, Mental and Behavioural Disorders, or Bipolarity, unspecified. Participants take part in a digital support tool and complete follow-up assessments.

In United Kingdom
Why is this study shown?

This study is directly about Bipolarity.

BipolarityOther
Countries
United Kingdom
Sponsor
Lancaster University (UK)
Condition
Bipolarity
Device study icon
RecruitingISRCTN05663421

A study on a sensor-based “Social Information Monitoring for people with Bipolarity” (SIMBA) via smart phones

This observational study is following people with F31, Mental and Behavioural Disorders, or bipolarity to understand outcomes over time. Participants mainly provide questionnaire, assessment, or follow-up information rather than receiving a new study treatment.

In Germany
Why is this study shown?

This study is directly about Bipolarity.

BipolarityOtherOver 18 Years
Countries
Germany
Sponsor
Investment & Development Bank of Lower Saxony – Nbank (Germany)
Condition
Bipolarity
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.